Jesús
San Miguel Izquierdo
Consultor Investigador
University Hospital of Würzburg
Wurzburgo, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital of Würzburg (3)
2021
-
Idecabtagene vicleucel in relapsed and refractory multiple myeloma
New England Journal of Medicine, Vol. 384, Núm. 8, pp. 705-716
2020
-
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Blood Cancer Journal, Vol. 10, Núm. 9
2015
-
Elotuzumab therapy for relapsed or refractory multiple myeloma
New England Journal of Medicine, Vol. 373, Núm. 7, pp. 621-631